(Q42171392)

17 October 2017

title

The utility of observational studies in clinical decision making: lessons learned from statin trials (English)

1 reference

17 October 2017

1 reference

1 reference

JoAnne M Foody

1

1 reference

17 October 2017

Phillip M Mendys

series ordinal

2

1 reference

17 October 2017

Larry Z Liu

series ordinal

3

1 reference

17 October 2017

Ross J Simpson

series ordinal

4

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

17 October 2017

published in

Postgraduate Medicine

1 reference

17 October 2017

volume

122

1 reference

17 October 2017

issue

3

1 reference

17 October 2017

page(s)

222-229

1 reference

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Mortality in relation to smoking: 50 years' observations on male British doctors

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Homogeneity in the relationship of serum cholesterol to coronary deaths across different cultures: 40-year follow-up of the Seven Countries Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

European guidelines on cardiovascular disease prevention in clinical practice: executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis pr

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Comparison of cardiovascular event rates in patients without cardiovascular disease in whom atorvastatin or simvastatin was newly initiated

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed population

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Differences between statins on clinical endpoints: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

SLCO1B1 variants and statin-induced myopathy--a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

NICE on lipid modification: NICE's simplified approach to lipids will not work

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.05.2161

21 January 2018

Identifiers

DOI

10.3810/PGM.2010.05.2161

1 reference

release_kksi3tqcfnbgvg5iaqqmln5pje

17 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kksi3tqcfnbgvg5iaqqmln5pje

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference